Indications for an early invasive strategy in NSTE-ACS patients

B. Zwart; J. M. ten Berg; A. W. van't Hof; P. A. L. Tonino; Y. Appelman; A. H. Liem; F. Arslan; J. Waltenberger; J. W. Jukema; R. J. de Winter; P. Damman

doi:10.1007/s12471-019-01337-5

Indications for an early invasive strategy in NSTE-ACS patients

B. Zwart^*
, J. M. ten Berg
, A. W. van't Hof
, P. A. L. Tonino
, Y. Appelman
, A. H. Liem
, F. Arslan
, J. Waltenberger
, J. W. Jukema
, R. J. de Winter
, P. Damman

^*Corresponding author for this work

Research output: Contribution to journal › Article › Academic › peer-review

Abstract

An early invasive strategy in patients who have acute coronary syndrome without ST-elevation (NSTE-ACS) can improve clinical outcome in high-risk subgroups. According to the current guidelines of the European Society of Cardiology (ESC), the majority of NSTE-ACS patients are classified as "high-risk". We propose to prioritise patients with a global registry of acute coronary events (GRACE) risk score >140 over patients with isolated troponin rise or electrocardiographic changes and a GRACE risk score

Original language	English
Pages (from-to)	131-135
Number of pages	5
Journal	Netherlands Heart Journal
Volume	28
Issue number	3
Early online date	6 Nov 2019
DOIs	https://doi.org/10.1007/s12471-019-01337-5
Publication status	Published - Mar 2020

Keywords

ACUTE CORONARY SYNDROMES
Acute coronary syndrome
Coronary angiography
IMMEDIATE
LATE INTERVENTION
MANAGEMENT
METAANALYSIS
Timing
UNSTABLE ANGINA
GUIDELINES

Access to Document

10.1007/s12471-019-01337-5Licence: CC BY

Cite this

@article{5535139a631c4a84bb2dfd2508529148,

title = "Indications for an early invasive strategy in NSTE-ACS patients",

abstract = "An early invasive strategy in patients who have acute coronary syndrome without ST-elevation (NSTE-ACS) can improve clinical outcome in high-risk subgroups. According to the current guidelines of the European Society of Cardiology (ESC), the majority of NSTE-ACS patients are classified as {"}high-risk{"}. We propose to prioritise patients with a global registry of acute coronary events (GRACE) risk score >140 over patients with isolated troponin rise or electrocardiographic changes and a GRACE risk score",

keywords = "ACUTE CORONARY SYNDROMES, Acute coronary syndrome, Coronary angiography, IMMEDIATE, LATE INTERVENTION, MANAGEMENT, METAANALYSIS, Timing, UNSTABLE ANGINA, GUIDELINES",

author = "B. Zwart and \{ten Berg\}, \{J. M.\} and \{van't Hof\}, \{A. W.\} and Tonino, \{P. A. L.\} and Y. Appelman and Liem, \{A. H.\} and F. Arslan and J. Waltenberger and Jukema, \{J. W.\} and \{de Winter\}, \{R. J.\} and P. Damman",

note = "Funding Information: J.W. Jukema/his department has received research grants from and/or was speaker (with or without lecture fees) at meetings, including CME accredited meetings, sponsored by Amgen, Astra-Zeneca, Biotronik, Boston Scientific, Daiichi Sankyo, Lilly, Medtronic, Merck-Schering-Plough, Pfizer, Sanofi Aventis, The Medicine Company, the Netherlands Heart Foundation, CardioVascular Research the Netherlands (CVON), the Interuniversity Cardiology Institute of the Netherlands and the European Community Framework KP7 Programme. B. Zwart, J.M. ten Berg, A.W. van {\textquoteright}t Hof, P.A.L. Tonino, Y. Appelman, A.H. Liem, F. Arslan, J. Waltenberger, R.J. de Winter and P. Damman declare that they have no competing interests. Publisher Copyright: {\textcopyright} 2019, The Author(s).",

year = "2020",

month = mar,

doi = "10.1007/s12471-019-01337-5",

language = "English",

volume = "28",

pages = "131--135",

journal = "Netherlands Heart Journal",

issn = "1568-5888",

publisher = "Bohn Stafleu van Loghum",

number = "3",

}

TY - JOUR

T1 - Indications for an early invasive strategy in NSTE-ACS patients

AU - Zwart, B.

AU - ten Berg, J. M.

AU - van't Hof, A. W.

AU - Tonino, P. A. L.

AU - Appelman, Y.

AU - Liem, A. H.

AU - Arslan, F.

AU - Waltenberger, J.

AU - Jukema, J. W.

AU - de Winter, R. J.

AU - Damman, P.

N1 - Funding Information: J.W. Jukema/his department has received research grants from and/or was speaker (with or without lecture fees) at meetings, including CME accredited meetings, sponsored by Amgen, Astra-Zeneca, Biotronik, Boston Scientific, Daiichi Sankyo, Lilly, Medtronic, Merck-Schering-Plough, Pfizer, Sanofi Aventis, The Medicine Company, the Netherlands Heart Foundation, CardioVascular Research the Netherlands (CVON), the Interuniversity Cardiology Institute of the Netherlands and the European Community Framework KP7 Programme. B. Zwart, J.M. ten Berg, A.W. van ’t Hof, P.A.L. Tonino, Y. Appelman, A.H. Liem, F. Arslan, J. Waltenberger, R.J. de Winter and P. Damman declare that they have no competing interests. Publisher Copyright: © 2019, The Author(s).

PY - 2020/3

Y1 - 2020/3

N2 - An early invasive strategy in patients who have acute coronary syndrome without ST-elevation (NSTE-ACS) can improve clinical outcome in high-risk subgroups. According to the current guidelines of the European Society of Cardiology (ESC), the majority of NSTE-ACS patients are classified as "high-risk". We propose to prioritise patients with a global registry of acute coronary events (GRACE) risk score >140 over patients with isolated troponin rise or electrocardiographic changes and a GRACE risk score

AB - An early invasive strategy in patients who have acute coronary syndrome without ST-elevation (NSTE-ACS) can improve clinical outcome in high-risk subgroups. According to the current guidelines of the European Society of Cardiology (ESC), the majority of NSTE-ACS patients are classified as "high-risk". We propose to prioritise patients with a global registry of acute coronary events (GRACE) risk score >140 over patients with isolated troponin rise or electrocardiographic changes and a GRACE risk score

KW - ACUTE CORONARY SYNDROMES

KW - Acute coronary syndrome

KW - Coronary angiography

KW - IMMEDIATE

KW - LATE INTERVENTION

KW - MANAGEMENT

KW - METAANALYSIS

KW - Timing

KW - UNSTABLE ANGINA

KW - GUIDELINES

U2 - 10.1007/s12471-019-01337-5

DO - 10.1007/s12471-019-01337-5

M3 - Article

C2 - 31696408

SN - 1568-5888

VL - 28

SP - 131

EP - 135

JO - Netherlands Heart Journal

JF - Netherlands Heart Journal

IS - 3

ER -

Indications for an early invasive strategy in NSTE-ACS patients

Abstract

Keywords

Access to Document

Fingerprint

Cite this